ATE226094T1 - Verfahren zur arzneistoffabgabe mittels gentherapie - Google Patents

Verfahren zur arzneistoffabgabe mittels gentherapie

Info

Publication number
ATE226094T1
ATE226094T1 AT96913661T AT96913661T ATE226094T1 AT E226094 T1 ATE226094 T1 AT E226094T1 AT 96913661 T AT96913661 T AT 96913661T AT 96913661 T AT96913661 T AT 96913661T AT E226094 T1 ATE226094 T1 AT E226094T1
Authority
AT
Austria
Prior art keywords
medicinal
gene therapy
delivering
pharmaceuticals
organs
Prior art date
Application number
AT96913661T
Other languages
English (en)
Inventor
Karl Tryggvason
Olavi Lukkarinen
Pirkko Heikkilae
Teija Parpala
Original Assignee
Karl Tryggvason
Olavi Lukkarinen
Pirkko Heikkilae
Teija Parpala
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karl Tryggvason, Olavi Lukkarinen, Pirkko Heikkilae, Teija Parpala filed Critical Karl Tryggvason
Application granted granted Critical
Publication of ATE226094T1 publication Critical patent/ATE226094T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96913661T 1995-05-16 1996-05-16 Verfahren zur arzneistoffabgabe mittels gentherapie ATE226094T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44218995A 1995-05-16 1995-05-16
PCT/IB1996/000463 WO1996036363A1 (en) 1995-05-16 1996-05-16 Method for pharmaceutical delivery

Publications (1)

Publication Number Publication Date
ATE226094T1 true ATE226094T1 (de) 2002-11-15

Family

ID=23755860

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96913661T ATE226094T1 (de) 1995-05-16 1996-05-16 Verfahren zur arzneistoffabgabe mittels gentherapie

Country Status (7)

Country Link
US (2) US5871464A (de)
EP (1) EP0831919B1 (de)
AT (1) ATE226094T1 (de)
AU (1) AU5658196A (de)
DE (1) DE69624355T2 (de)
ES (1) ES2187648T3 (de)
WO (1) WO1996036363A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638264B1 (en) * 1995-05-16 2003-10-28 Biostratum Incorporation Perfusion apparatus and methods for pharmaceutical delivery
US6342214B1 (en) * 1995-05-16 2002-01-29 Karl Tryggvason Method for viral vector delivery
US6192138B1 (en) * 1997-05-08 2001-02-20 Kabushiki Kaisha Toshiba Apparatus and method for embedding/unembedding supplemental information
JP2002541792A (ja) * 1999-04-09 2002-12-10 アベンテイス・フアルマ・ソシエテ・アノニム 感染性の組換えアデノウイルスの保存用組成物
US20070166292A1 (en) * 1999-04-14 2007-07-19 Breonics, Inc. System for exsanguinous metabolic support of an organ or tissue
US6455257B1 (en) * 2001-02-16 2002-09-24 Richard D. Fuerle Designer diseases
US20040170950A1 (en) * 2002-09-12 2004-09-02 Prien Samuel D. Organ preservation apparatus and methods
US20050153271A1 (en) * 2004-01-13 2005-07-14 Wenrich Marshall S. Organ preservation apparatus and methods
US7722596B2 (en) * 2004-02-26 2010-05-25 Osprey Medical, Inc. Regional cardiac tissue treatment
US20060182724A1 (en) * 2005-02-15 2006-08-17 Riordan Neil H Method for expansion of stem cells
US8152786B2 (en) * 2006-11-07 2012-04-10 Osprey Medical, Inc. Collection catheter and kit
US20080145919A1 (en) * 2006-12-18 2008-06-19 Franklin Thomas D Portable organ and tissue preservation apparatus, kit and methods
US9050400B2 (en) * 2008-08-12 2015-06-09 Osprey Medical, Inc. Remote sensing catheter system and methods
US20100041984A1 (en) * 2008-08-12 2010-02-18 James Edward Shapland Impedance sensing device and catheter system
US9320269B2 (en) 2009-09-25 2016-04-26 John Brassil Organ preservation system
US9295816B2 (en) * 2009-12-09 2016-03-29 Osprey Medical, Inc. Catheter with distal and proximal ports
WO2013023126A2 (en) 2011-08-11 2013-02-14 Osprey Medical Inc. Systems and methods for limb treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328470A (en) * 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5521291A (en) * 1991-09-30 1996-05-28 Boehringer Ingelheim International, Gmbh Conjugates for introducing nucleic acid into higher eucaryotic cells
US5252479A (en) * 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US5338662A (en) * 1992-09-21 1994-08-16 Bio-Preserve Medical Corporation Organ perfusion device
US5336178A (en) * 1992-11-02 1994-08-09 Localmed, Inc. Intravascular catheter with infusion array
US5382229A (en) * 1993-09-21 1995-01-17 Abbott Laboratories Irrigation solution re-circulating system

Also Published As

Publication number Publication date
WO1996036363A1 (en) 1996-11-21
EP0831919B1 (de) 2002-10-16
US5871464A (en) 1999-02-16
AU5658196A (en) 1996-11-29
DE69624355D1 (de) 2002-11-21
ES2187648T3 (es) 2003-06-16
DE69624355T2 (de) 2003-06-12
EP0831919A1 (de) 1998-04-01
US6689090B1 (en) 2004-02-10

Similar Documents

Publication Publication Date Title
DE69624355D1 (de) Verfahren zur arzneistoffabgabe mittels gentherapie
ATE241351T1 (de) Isobutylgaba und dessen derivate zur schmerzbehandlung
DE69615561D1 (de) Polyether-blockcopolymer micellare zusammensetzungen zur zielgerichteten verabreichung biologischer stoffe
DK1035834T3 (da) Osmotisk doseringsform omfattende en første og anden coating
ATE185083T1 (de) Vorrichtung zur verabreichung von medikamenten und genen durch elektroporation
ATE298259T1 (de) Vorrichtung zur lokalen verabreichung einer arznei in einer körperhöhle
DE60324427D1 (de) Verfahren zur modulation der tubulindeacetylase-aktivität
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
BR9610480A (pt) Inibição do fator alfa de necrose tumoral
PT946151E (pt) Forma de dosagem de dose crescente
DE69814394D1 (de) Verwendung von levobupivacain
AU6682598A (en) Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
WO1999016791A3 (en) Compounds and methods for regulating cell adhesion
ATE273698T1 (de) Systeme zur arzneistoffabgabe an schleimhäute
SE9603725D0 (sv) New teatment
ATE371031T1 (de) Herpes-simplex virus, das das gen von interleukin-12 exprimiert, und dessen verwendung zur behandlung von krebs
ATE208200T1 (de) Transdermales therapeutisches system (tts) zur verabreichung von testosteron
DE69622989D1 (de) Kombiniertes therapeutisches verfahren zur behandlung von hyperproliferativen krankheiten
ATE255411T1 (de) Hyaluronsäurerezeptoren bindende stoffe und deren verwendung zur behandlung von tumoren und restenose
AU4037299A (en) Genetically-modified fibroblasts and the use thereof
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
UA7192A (uk) Спосіб масажу біологічно активних точок і інструмент для масажу біологічно активних точок в.в. шушковського
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору
GEP20002034B (en) Analogs of Keratinocyte Growth Factor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties